| Popis: |
Baharudin Abdullah,1 Amir Hamzah Abdul Latiff,2 Anura Michelle Manuel,3 Faizah Mohamed Jamli,4 Harvinder Singh Dalip Singh,5 Intan Hakimah Ismail,6 Jeevanan Jahendran,2 Jeyasakthy Saniasiaya,7Kent Chee Keen Woo,8 Phaik Choo Khoo,9 Kuljit Singh,3 Nurashikin Mohammad,10 Sakinah Mohamad,1 Salina Husain,11 Ralph Mösges12,13 1Department of Otorhinolaryngology - Head and Neck Surgery, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia; 2Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia; 3Prince Court Medical Centre, Kuala Lumpur, Malaysia; 4Department of Paediatrics, Hospital Serdang, Selangor, Malaysia; 5Department of Otorhinolaryngology - Head and Neck Surgery, Hospital Raja Permaisuri Bainun, Ipoh, Perak; 6Department of Paediatrics, Universiti Putra Malaysia, Selangor, Malaysia; 7Department of Otorhinolaryngology, Universiti Malaya, Kuala Lumpur, Malaysia; 8Gleneagles Hospital Kuala Lumpur, Kuala Lumpur, Malaysia; 9Subang Jaya Medical Centre (SJMC), Selangor, Malaysia; 10Department of Internal Medicine, Universiti Sains Malaysia, Kelantan, Malaysia; 11Department of Otorhinolaryngology-Head & Neck Surgery, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia; 12Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany; 13ClinCompetence Cologne GmbH, Cologne, GermanyCorrespondence: Baharudin Abdullah, Department of Otorhinolaryngology - Head and Neck Surgery, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia, Tel +60 97676416, Fax +60 97676424, Email baharudin@usm.my; profbaha@gmail.comAbstract: The goal of allergic rhinitis (AR) management is to achieve satisfactory symptom control to ensure good quality of life. Most patients with AR are currently treated with pharmacotherapy. However, knowledge gaps on the use of pharmacotherapy still exist among physicians, particularly in the primary care setting, despite the availability of guideline recommendations. Furthermore, it is common for physicians in the secondary care setting to express uncertainty regarding the use of new combination therapies like intranasal corticosteroid plus antihistamine combinations. Inadequate treatment leads to significant reduction of quality of life that affects daily activities at home, work, and school. With these concerns in mind, a practical consensus statement was developed to complement existing guidelines on the rational use of pharmacotherapy in both the primary and secondary care settings.Keywords: allergic rhinitis, pharmacotherapy, consensus, primary care, secondary care, Malaysia |
